高榕创投

高榕创投

@gaorong

创造美好生活

499 articles

Articles

Cornerstone Robotics, a Leader in Innovative Surgical Robot Technology, Closes RMB 500 Million Series B Funding Round

We have completed a multi-pipeline layout covering soft-tissue surgical robots and other major specialty surgical robots.

Congratulations to UJU Interactive on its Successful Listing on the Hong Kong Stock Exchange | Gaorong Ventures News

A leading player in online short-video marketing solutions.

Gaorong Monthly · October | Gaorong Ventures Named Among Zero2IPO's Top 10 VC Firms of the Year; Nuro Closes Major Series D Round

Autonomous driving, healthcare, and chip sectors see new funding rounds; Genki Forest unveils "Triple Zero Factory" strategy; Dingdong Maicai stabilizes prices and ensures supply.

Nuro Announces $600 Million Series D to Accelerate Commercialization of Autonomous Delivery Vehicles

Less Driving. More Thriving.

Smart home unicorn Aqara raises 1 billion yuan in Series C funding

Leading IoT innovation, creating smart homes that truly understand you.

Xingji Announces Completion of Hundreds of Millions of RMB in Series A Funding, Focused on Innovation in Digital Implementation EDA Products

Dramatically improves chip design efficiency and helps enable first-time-right, rapid volume production.

Congratulations on the Establishment of Peking University's School of Computer Science, with Gaorong Ventures Donating to Support Education

On October 24, the School of Computer Science at Peking University was officially established.

Mirxes Completes $87 Million Series C Round to Develop Early Cancer Screening Products Based on Leading miRNA Technology

Focused on microRNA technology, dedicated to early disease diagnosis.

Privacy-preserving computation and data-circulation leader **Huakong Qingjiao** closes RMB 500 million Series B round

Accelerate the development of data-factor circulation infrastructure.

Gaorong Bulletin · September | Gaorong Ventures Ranks Top 3 in 2021 VC Fund Returns, Milestones for Cross-Border Services, New Drug R&D, and New Brands

Consumer investment is returning to natural consumer demand, and medical technology innovation is emerging.